Bond WuXi AppTec (Hong Kong) Ltd 0% ( XS2919099650 ) in USD

Issuer WuXi AppTec (Hong Kong) Ltd
Market price 100 %  ▲ 
Country  China
ISIN code  XS2919099650 ( in USD )
Interest rate 0%
Maturity 18/10/2025 - Bond has expired



Prospectus brochure in PDF format is unavailable at this time
We will provide it as soon as possible

Minimal amount 200 000 USD
Total amount 500 000 000 USD
Detailed description WuXi AppTec [Hong Kong] Ltd. is a Hong Kong-based subsidiary of WuXi AppTec Co., Ltd., a leading global pharmaceutical and biopharmaceutical technology platform company providing integrated research, development and manufacturing services.

A debt instrument issued by WuXi AppTec [HongKong] Ltd, identified by the ISIN code XS2919099650, presents itself as a notable offering in the fixed-income market. WuXi AppTec [HongKong] Ltd is a key entity within the broader WuXi AppTec Group, a globally recognized leader in providing comprehensive R&D and manufacturing services for the pharmaceutical, biotechnology, and medical device industries. Headquartered in China, the parent company, WuXi AppTec, has established a significant global footprint by assisting pharmaceutical and biotechnology companies in accelerating their drug discovery and development processes, from early research to commercial manufacturing. This particular bond issue, originating from China, is denominated in US Dollars (USD) and carries a total issue size of 500,000,000 USD. Its current market price stands at 100% of its nominal value. A distinguishing feature of this bond is its zero-coupon structure, evidenced by its 0% interest rate, meaning investors will not receive periodic interest payments. Instead, the principal amount will be repaid in a single lump sum upon the bond's maturity on October 18, 2025. The stated 'payment frequency' of 1 refers to this sole principal redemption at the maturity date. Returns for zero-coupon bonds are typically derived from the difference between the acquisition price and the par value at redemption, although this bond is currently trading at 100% of its nominal value. With a minimum purchase size set at 200,000 USD, this instrument is designed for larger-scale investors seeking exposure to a debt vehicle from a prominent player in the life sciences sector.